Febuxostat
- Product NDC
- 71610-585
- 11-digit product format
- 716100585
- Labeler code
- 71610
- Product ID
- 71610-585_2f9f373e-d40d-4163-90a9-f53b7eb24cd4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- febuxostat
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA210292
- Marketing category
- ANDA
- Marketing start
- 2020-09-28
- Marketing end
- 0000-00-00
- Substance
- FEBUXOSTAT
- Active strength
- 40 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-585-60 | Febuxostat | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-585 | FEBUXOSTAT TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC, 1 package rows | 20210811_8ed19d23-b91c-4e5a-b1c5-24e355b8c0a4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-585-60 | 71610058560 | 90 TABLET in 1 BOTTLE (71610-585-60) | 90 tablet | 2021-07-26 | 0000-00-00 | No | No | Current |